Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Covid-19 and Substance Use Disorders: Recommendations to a Comprehensive Healthcare Response. an International Society of Addiction Medicine Practice and Policy Interest Group Position Paper Publisher



Farhoudian A1, 2 ; Baldacchino A3 ; Clark N4, 5 ; Gerra G6 ; Ekhtiari H7 ; Dom G8 ; Mokri A1 ; Sadeghi M9 ; Nematollahi P10 ; Demasi M4 ; Schutz CG11 ; Hashemian SM12 ; Tabarsi P13 ; Galeasinger S14 Show All Authors
Authors
  1. Farhoudian A1, 2
  2. Baldacchino A3
  3. Clark N4, 5
  4. Gerra G6
  5. Ekhtiari H7
  6. Dom G8
  7. Mokri A1
  8. Sadeghi M9
  9. Nematollahi P10
  10. Demasi M4
  11. Schutz CG11
  12. Hashemian SM12
  13. Tabarsi P13
  14. Galeasinger S14
  15. Carra G15
  16. Clausen T16
  17. Kouimtsidis C17
  18. Tolomeo S18
  19. Radfar SR2, 19
  20. Razaghi EM1
Show Affiliations
Authors Affiliations
  1. 1. Department of Psychiatry, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Substance Abuse and Dependence Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran
  3. 3. Division of Population and Behavioral Sciences, St Andrews University Medical School, University of St Andrews, United Kingdom
  4. 4. North Richmond Community Health, Melbourne, VIC, Australia
  5. 5. Royal Melbourne Hospital, Melbourne, VIC, Australia
  6. 6. Drug Prevention and Health Branch, Division for Operations, United Nations Office on Drugs and Crime, Vienna, Austria
  7. 7. Laureate Institute for Brain Research, Tulsa, OK, United States
  8. 8. Collaborative Antwerp Psychiatric Research Institute, University of Antwerp, Antwerp, Belgium
  9. 9. Aftab Mehrvarzi Substance Abuse Treatment Center, Tehran, Iran
  10. 10. Cancer Prevention Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
  11. 11. Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada
  12. 12. Chronic Respiratory Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  13. 13. Clinical Tuberculosis and Epidemiology Research Center, National Research Institute for Tuberculosis and Lung Disease (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran
  14. 14. Institute for Innovation and Improvement, IWaitemat. DHB, Centre for Addictions Research, University of Auckland, Auckland, New Zealand
  15. 15. Department of Medicine and Surgery, Section of Psychiatry, University of Milan Bicocca, Milan, Italy
  16. 16. Norwegian Centre for Addiction Research (SERAF), University of Oslo, Oslo, Norway
  17. 17. General Secretariat of Prime Minister, Ministry of Health, Athens, Greece
  18. 18. Department of Psychology, National University of Singapore (NUS), Singapore
  19. 19. Integrated Substance Abuse Programs, University of California, Los Angeles, CA, United States

Source: Basic and Clinical Neuroscience Published:2020


Abstract

Coronavirus Disease 2019 (COVID-19) is escalating all over the world and has higher morbidities and mortalities in certain vulnerable populations. People Who Use Drugs (PWUD) are a marginalized and stigmatized group with weaker immunity responses, vulnerability to stress, poor health conditions, high-risk behaviors, and lower access to health care services. These conditions put them at a higher risk of COVID-19 infection and its complications. In this paper, an international group of experts on addiction medicine, infectious diseases, and disaster psychiatry explore the possible raised concerns in this issue and provide recommendations to manage the comorbidity of COVID-19 and Substance Use Disorder (SUD). © 2020 Iran University of Medical Sciences. All rights reserved.
Other Related Docs
9. Epidemiology, Virology, Clinical Features, Diagnosis, and Treatment of Sars-Cov-2 Infection, Journal of Experimental and Clinical Medicine (Turkey) (2021)
10. Sars-Cov-2 (Covid-19): New Discoveries and Current Challenges, Applied Sciences (Switzerland) (2020)
12. Cytokines and Micrornas in Sars-Cov-2: What Do We Know?, Molecular Therapy Nucleic Acids (2022)
14. T-Cell Immunophenotyping in Covid-19 Pneumonia, Journal of Research in Medical Sciences (2021)
17. Corticosteroid Therapy for 2019 Novel Coronavirus: Lessons From Sars and Mers, Avicenna Journal of Clinical Microbiology and Infection (2021)
19. Cancer Care Management During the Covid-19 Pandemic, Risk Management and Healthcare Policy (2020)
23. Clinical Display, Diagnostics and Genetic Implication of Novel Coronavirus (Covid-19) Epidemic, European Review for Medical and Pharmacological Sciences (2020)
26. A Narrative Review of Covid-19: The New Pandemic Disease, Iranian Journal of Medical Sciences (2020)
38. A Comprehensive Review of Therapeutic Options for Covid-19, Ethiopian Journal of Health Development (2022)
39. Recent Findings of Coronavirus: The Pathogenesis and Treatment, Journal of Isfahan Medical School (2020)